New research confirms that chronic immune-related adverse events (AEs) from adjuvant anti-programmable cell death-1 (anti–PD-1) immunotherapy are common, can affect diverse organ systems, and will ...

A type of nanoparticle called a metal organic framework (MOF) could be used to deliver vaccines and act as an adjuvant. Researchers find these particles provoke a strong immune response by activating ...

In a recent review published in the Signal Transduction and Targeted Therapy Journal, a group of authors summarized adjuvant mechanisms, characteristics, and applications, seeking to overcome current ...

ATLANTA—A novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant to boost immune responses has provided complete protection against influenza viral ...

Dead tumor cells have been researched as potential adjuvants for cancer vaccines and immunotherapies, but new experiments in mice, headed by researchers at MIT, have demonstrated that a patient’s own ...

Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...